Ask Warren

Aminologics

074430 · KOSDAQ · ₩074430 · 아미노로직스

₩1,009▲ ₩9 (0.90%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩8.2B₩5.4B₩6.5B₩6B₩4.8B₩4.7B₩4B₩2.4B
Cost of sales₩4.4B₩2.9B₩3.3B₩3.1B₩3.1B₩2.6B₩3B₩3.2B
Gross profit₩3.8B₩2.5B₩3.2B₩2.9B₩1.7B₩2.1B₩989M−₩792M
Operating income₩2B₩630M₩1.5B₩1.4B₩216M₩512M−₩391M−₩2.1B
Net income−₩77M₩1.1B₩2.2B₩1.3B−₩2.2B₩2.3B−₩86M−₩2B
Net income to shareholders₩990M₩1.1B−₩258M₩1.4B₩90M₩2.3B−₩1.8B−₩1.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩90B₩88B₩84B₩83B₩87B₩59B₩57B₩58B
Current assets₩70B₩82B₩79B₩76B₩80B₩51B₩47B₩45B
Cash and equivalents₩23B₩31B₩26B₩25B₩29B₩22B₩19B₩18B
Total liabilities₩31B₩31B₩28B₩27B₩32B₩4.6B₩5.1B₩3.5B
Current liabilities₩31B₩30B₩28B₩26B₩31B₩3.9B₩4.3B₩2.7B
Borrowings₩16B₩16B₩15B₩12B₩14B₩1B₩1B₩1B
Total equity₩58B₩57B₩56B₩56B₩55B₩54B₩52B₩55B
Shareholders' equity₩58B₩57B₩56B₩56B₩55B₩54B₩52B₩55B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩256M₩4.6B₩1.6B−₩4.2B₩5.6B−₩466M₩507M₩1.3B
Free cash flow−₩256M₩4.6B₩1.6B−₩4.2B₩5.6B−₩466M₩507M₩1.3B

Consolidated where available. Amounts in won.

Also known as: Aminologics / 아미노로직스 / 074430 / KRX:074430

Source: KRX statistical information